Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Dermal Filler and Botolinum Toxin Market Growth 2022-2028

  • LP 4757013
  • 104 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Dermal Filler and Botolinum Toxin will have significant change from previous year. According to our (LP Information) latest study, the global Dermal Filler and Botolinum Toxin market size is USD million in 2022 from USD 11790 million in 2021, with a change of % between 2021 and 2022. The global Dermal Filler and Botolinum Toxin market size will reach USD 30300 million in 2028, growing at a CAGR of 14.4% over the analysis period.

The United States Dermal Filler and Botolinum Toxin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dermal Filler and Botolinum Toxin market, reaching US$ million by the year 2028. As for the Europe Dermal Filler and Botolinum Toxin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Dermal Filler and Botolinum Toxin players cover Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, and Anika Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermal Filler and Botolinum Toxin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Hyaluronic Acid Based Fillers

Non-Hyaluronic Acid Based Fillers

Botulinum Toxin

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Aesthetic Restoration

Wrinkle Reduction

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Allergan

Galderma

Merz Pharma GmbH & Co. KGaA

Anika Therapeutics

Suneva Medical

Contura

HUGEL

Grex Pharma

Daewoong Pharmaceuticals

Medy-Tox

TEOXANE Laboratories

SciVision Biotech

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dermal Filler and Botolinum Toxin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Dermal Filler and Botolinum Toxin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Dermal Filler and Botolinum Toxin by Country/Region, 2017, 2022 & 2028

2.2 Dermal Filler and Botolinum Toxin Segment by Type

2.2.1 Hyaluronic Acid Based Fillers

2.2.2 Non-Hyaluronic Acid Based Fillers

2.2.3 Botulinum Toxin

2.3 Dermal Filler and Botolinum Toxin Sales by Type

2.3.1 Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)

2.3.2 Global Dermal Filler and Botolinum Toxin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Dermal Filler and Botolinum Toxin Sale Price by Type (2017-2022)

2.4 Dermal Filler and Botolinum Toxin Segment by Application

2.4.1 Aesthetic Restoration

2.4.2 Wrinkle Reduction

2.5 Dermal Filler and Botolinum Toxin Sales by Application

2.5.1 Global Dermal Filler and Botolinum Toxin Sale Market Share by Application (2017-2022)

2.5.2 Global Dermal Filler and Botolinum Toxin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Dermal Filler and Botolinum Toxin Sale Price by Application (2017-2022)

3 Global Dermal Filler and Botolinum Toxin by Company

3.1 Global Dermal Filler and Botolinum Toxin Breakdown Data by Company

3.1.1 Global Dermal Filler and Botolinum Toxin Annual Sales by Company (2020-2022)

3.1.2 Global Dermal Filler and Botolinum Toxin Sales Market Share by Company (2020-2022)

3.2 Global Dermal Filler and Botolinum Toxin Annual Revenue by Company (2020-2022)

3.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Company (2020-2022)

3.2.2 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company (2020-2022)

3.3 Global Dermal Filler and Botolinum Toxin Sale Price by Company

3.4 Key Manufacturers Dermal Filler and Botolinum Toxin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Dermal Filler and Botolinum Toxin Product Location Distribution

3.4.2 Players Dermal Filler and Botolinum Toxin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Dermal Filler and Botolinum Toxin by Geographic Region

4.1 World Historic Dermal Filler and Botolinum Toxin Market Size by Geographic Region (2017-2022)

4.1.1 Global Dermal Filler and Botolinum Toxin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Dermal Filler and Botolinum Toxin Annual Revenue by Geographic Region

4.2 World Historic Dermal Filler and Botolinum Toxin Market Size by Country/Region (2017-2022)

4.2.1 Global Dermal Filler and Botolinum Toxin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Dermal Filler and Botolinum Toxin Annual Revenue by Country/Region

4.3 Americas Dermal Filler and Botolinum Toxin Sales Growth

4.4 APAC Dermal Filler and Botolinum Toxin Sales Growth

4.5 Europe Dermal Filler and Botolinum Toxin Sales Growth

4.6 Middle East & Africa Dermal Filler and Botolinum Toxin Sales Growth

5 Americas

5.1 Americas Dermal Filler and Botolinum Toxin Sales by Country

5.1.1 Americas Dermal Filler and Botolinum Toxin Sales by Country (2017-2022)

5.1.2 Americas Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022)

5.2 Americas Dermal Filler and Botolinum Toxin Sales by Type

5.3 Americas Dermal Filler and Botolinum Toxin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dermal Filler and Botolinum Toxin Sales by Region

6.1.1 APAC Dermal Filler and Botolinum Toxin Sales by Region (2017-2022)

6.1.2 APAC Dermal Filler and Botolinum Toxin Revenue by Region (2017-2022)

6.2 APAC Dermal Filler and Botolinum Toxin Sales by Type

6.3 APAC Dermal Filler and Botolinum Toxin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Dermal Filler and Botolinum Toxin by Country

7.1.1 Europe Dermal Filler and Botolinum Toxin Sales by Country (2017-2022)

7.1.2 Europe Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022)

7.2 Europe Dermal Filler and Botolinum Toxin Sales by Type

7.3 Europe Dermal Filler and Botolinum Toxin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dermal Filler and Botolinum Toxin by Country

8.1.1 Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022)

8.2 Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Type

8.3 Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Dermal Filler and Botolinum Toxin

10.3 Manufacturing Process Analysis of Dermal Filler and Botolinum Toxin

10.4 Industry Chain Structure of Dermal Filler and Botolinum Toxin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Dermal Filler and Botolinum Toxin Distributors

11.3 Dermal Filler and Botolinum Toxin Customer

12 World Forecast Review for Dermal Filler and Botolinum Toxin by Geographic Region

12.1 Global Dermal Filler and Botolinum Toxin Market Size Forecast by Region

12.1.1 Global Dermal Filler and Botolinum Toxin Forecast by Region (2023-2028)

12.1.2 Global Dermal Filler and Botolinum Toxin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Dermal Filler and Botolinum Toxin Forecast by Type

12.7 Global Dermal Filler and Botolinum Toxin Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Dermal Filler and Botolinum Toxin Product Offered

13.1.3 Allergan Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 Galderma

13.2.1 Galderma Company Information

13.2.2 Galderma Dermal Filler and Botolinum Toxin Product Offered

13.2.3 Galderma Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Galderma Main Business Overview

13.2.5 Galderma Latest Developments

13.3 Merz Pharma GmbH & Co. KGaA

13.3.1 Merz Pharma GmbH & Co. KGaA Company Information

13.3.2 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Offered

13.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merz Pharma GmbH & Co. KGaA Main Business Overview

13.3.5 Merz Pharma GmbH & Co. KGaA Latest Developments

13.4 Anika Therapeutics

13.4.1 Anika Therapeutics Company Information

13.4.2 Anika Therapeutics Dermal Filler and Botolinum Toxin Product Offered

13.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Anika Therapeutics Main Business Overview

13.4.5 Anika Therapeutics Latest Developments

13.5 Suneva Medical

13.5.1 Suneva Medical Company Information

13.5.2 Suneva Medical Dermal Filler and Botolinum Toxin Product Offered

13.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Suneva Medical Main Business Overview

13.5.5 Suneva Medical Latest Developments

13.6 Contura

13.6.1 Contura Company Information

13.6.2 Contura Dermal Filler and Botolinum Toxin Product Offered

13.6.3 Contura Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Contura Main Business Overview

13.6.5 Contura Latest Developments

13.7 HUGEL

13.7.1 HUGEL Company Information

13.7.2 HUGEL Dermal Filler and Botolinum Toxin Product Offered

13.7.3 HUGEL Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 HUGEL Main Business Overview

13.7.5 HUGEL Latest Developments

13.8 Grex Pharma

13.8.1 Grex Pharma Company Information

13.8.2 Grex Pharma Dermal Filler and Botolinum Toxin Product Offered

13.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Grex Pharma Main Business Overview

13.8.5 Grex Pharma Latest Developments

13.9 Daewoong Pharmaceuticals

13.9.1 Daewoong Pharmaceuticals Company Information

13.9.2 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Offered

13.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Daewoong Pharmaceuticals Main Business Overview

13.9.5 Daewoong Pharmaceuticals Latest Developments

13.10 Medy-Tox

13.10.1 Medy-Tox Company Information

13.10.2 Medy-Tox Dermal Filler and Botolinum Toxin Product Offered

13.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Medy-Tox Main Business Overview

13.10.5 Medy-Tox Latest Developments

13.11 TEOXANE Laboratories

13.11.1 TEOXANE Laboratories Company Information

13.11.2 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Offered

13.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 TEOXANE Laboratories Main Business Overview

13.11.5 TEOXANE Laboratories Latest Developments

13.12 SciVision Biotech

13.12.1 SciVision Biotech Company Information

13.12.2 SciVision Biotech Dermal Filler and Botolinum Toxin Product Offered

13.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 SciVision Biotech Main Business Overview

13.12.5 SciVision Biotech Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Dermal Filler and Botolinum Toxin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Dermal Filler and Botolinum Toxin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hyaluronic Acid Based Fillers

Table 4. Major Players of Non-Hyaluronic Acid Based Fillers

Table 5. Major Players of Botulinum Toxin

Table 6. Global Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)

Table 7. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)

Table 8. Global Dermal Filler and Botolinum Toxin Revenue by Type (2017-2022) & ($ million)

Table 9. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2017-2022)

Table 10. Global Dermal Filler and Botolinum Toxin Sale Price by Type (2017-2022) & (USD/MT)

Table 11. Global Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)

Table 12. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)

Table 13. Global Dermal Filler and Botolinum Toxin Revenue by Application (2017-2022)

Table 14. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2017-2022)

Table 15. Global Dermal Filler and Botolinum Toxin Sale Price by Application (2017-2022) & (USD/MT)

Table 16. Global Dermal Filler and Botolinum Toxin Sales by Company (2020-2022) & (K MT)

Table 17. Global Dermal Filler and Botolinum Toxin Sales Market Share by Company (2020-2022)

Table 18. Global Dermal Filler and Botolinum Toxin Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company (2020-2022)

Table 20. Global Dermal Filler and Botolinum Toxin Sale Price by Company (2020-2022) & (USD/MT)

Table 21. Key Manufacturers Dermal Filler and Botolinum Toxin Producing Area Distribution and Sales Area

Table 22. Players Dermal Filler and Botolinum Toxin Products Offered

Table 23. Dermal Filler and Botolinum Toxin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Dermal Filler and Botolinum Toxin Sales by Geographic Region (2017-2022) & (K MT)

Table 27. Global Dermal Filler and Botolinum Toxin Sales Market Share Geographic Region (2017-2022)

Table 28. Global Dermal Filler and Botolinum Toxin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Dermal Filler and Botolinum Toxin Sales by Country/Region (2017-2022) & (K MT)

Table 31. Global Dermal Filler and Botolinum Toxin Sales Market Share by Country/Region (2017-2022)

Table 32. Global Dermal Filler and Botolinum Toxin Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Dermal Filler and Botolinum Toxin Sales by Country (2017-2022) & (K MT)

Table 35. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Country (2017-2022)

Table 36. Americas Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2017-2022)

Table 38. Americas Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)

Table 39. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)

Table 40. Americas Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)

Table 41. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)

Table 42. APAC Dermal Filler and Botolinum Toxin Sales by Region (2017-2022) & (K MT)

Table 43. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Region (2017-2022)

Table 44. APAC Dermal Filler and Botolinum Toxin Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Dermal Filler and Botolinum Toxin Revenue Market Share by Region (2017-2022)

Table 46. APAC Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)

Table 47. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)

Table 48. APAC Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)

Table 49. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)

Table 50. Europe Dermal Filler and Botolinum Toxin Sales by Country (2017-2022) & (K MT)

Table 51. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Country (2017-2022)

Table 52. Europe Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2017-2022)

Table 54. Europe Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)

Table 55. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)

Table 56. Europe Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)

Table 57. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Country (2017-2022) & (K MT)

Table 59. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Type (2017-2022) & (K MT)

Table 63. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Dermal Filler and Botolinum Toxin Sales by Application (2017-2022) & (K MT)

Table 65. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Dermal Filler and Botolinum Toxin

Table 67. Key Market Challenges & Risks of Dermal Filler and Botolinum Toxin

Table 68. Key Industry Trends of Dermal Filler and Botolinum Toxin

Table 69. Dermal Filler and Botolinum Toxin Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Dermal Filler and Botolinum Toxin Distributors List

Table 72. Dermal Filler and Botolinum Toxin Customer List

Table 73. Global Dermal Filler and Botolinum Toxin Sales Forecast by Region (2023-2028) & (K MT)

Table 74. Global Dermal Filler and Botolinum Toxin Sales Market Forecast by Region

Table 75. Global Dermal Filler and Botolinum Toxin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Dermal Filler and Botolinum Toxin Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Dermal Filler and Botolinum Toxin Sales Forecast by Country (2023-2028) & (K MT)

Table 78. Americas Dermal Filler and Botolinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Dermal Filler and Botolinum Toxin Sales Forecast by Region (2023-2028) & (K MT)

Table 80. APAC Dermal Filler and Botolinum Toxin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Dermal Filler and Botolinum Toxin Sales Forecast by Country (2023-2028) & (K MT)

Table 82. Europe Dermal Filler and Botolinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Forecast by Country (2023-2028) & (K MT)

Table 84. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Dermal Filler and Botolinum Toxin Sales Forecast by Type (2023-2028) & (K MT)

Table 86. Global Dermal Filler and Botolinum Toxin Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Dermal Filler and Botolinum Toxin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Dermal Filler and Botolinum Toxin Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Dermal Filler and Botolinum Toxin Sales Forecast by Application (2023-2028) & (K MT)

Table 90. Global Dermal Filler and Botolinum Toxin Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Dermal Filler and Botolinum Toxin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Dermal Filler and Botolinum Toxin Revenue Market Share Forecast by Application (2023-2028)

Table 93. Allergan Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 94. Allergan Dermal Filler and Botolinum Toxin Product Offered

Table 95. Allergan Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 96. Allergan Main Business

Table 97. Allergan Latest Developments

Table 98. Galderma Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 99. Galderma Dermal Filler and Botolinum Toxin Product Offered

Table 100. Galderma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 101. Galderma Main Business

Table 102. Galderma Latest Developments

Table 103. Merz Pharma GmbH & Co. KGaA Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 104. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Offered

Table 105. Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 106. Merz Pharma GmbH & Co. KGaA Main Business

Table 107. Merz Pharma GmbH & Co. KGaA Latest Developments

Table 108. Anika Therapeutics Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 109. Anika Therapeutics Dermal Filler and Botolinum Toxin Product Offered

Table 110. Anika Therapeutics Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 111. Anika Therapeutics Main Business

Table 112. Anika Therapeutics Latest Developments

Table 113. Suneva Medical Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 114. Suneva Medical Dermal Filler and Botolinum Toxin Product Offered

Table 115. Suneva Medical Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 116. Suneva Medical Main Business

Table 117. Suneva Medical Latest Developments

Table 118. Contura Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 119. Contura Dermal Filler and Botolinum Toxin Product Offered

Table 120. Contura Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 121. Contura Main Business

Table 122. Contura Latest Developments

Table 123. HUGEL Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 124. HUGEL Dermal Filler and Botolinum Toxin Product Offered

Table 125. HUGEL Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 126. HUGEL Main Business

Table 127. HUGEL Latest Developments

Table 128. Grex Pharma Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 129. Grex Pharma Dermal Filler and Botolinum Toxin Product Offered

Table 130. Grex Pharma Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 131. Grex Pharma Main Business

Table 132. Grex Pharma Latest Developments

Table 133. Daewoong Pharmaceuticals Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 134. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Offered

Table 135. Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 136. Daewoong Pharmaceuticals Main Business

Table 137. Daewoong Pharmaceuticals Latest Developments

Table 138. Medy-Tox Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 139. Medy-Tox Dermal Filler and Botolinum Toxin Product Offered

Table 140. Medy-Tox Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 141. Medy-Tox Main Business

Table 142. Medy-Tox Latest Developments

Table 143. TEOXANE Laboratories Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 144. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Offered

Table 145. TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 146. TEOXANE Laboratories Main Business

Table 147. TEOXANE Laboratories Latest Developments

Table 148. SciVision Biotech Basic Information, Dermal Filler and Botolinum Toxin Manufacturing Base, Sales Area and Its Competitors

Table 149. SciVision Biotech Dermal Filler and Botolinum Toxin Product Offered

Table 150. SciVision Biotech Dermal Filler and Botolinum Toxin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 151. SciVision Biotech Main Business

Table 152. SciVision Biotech Latest Developments

List of Figures

Figure 1. Picture of Dermal Filler and Botolinum Toxin

Figure 2. Dermal Filler and Botolinum Toxin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Dermal Filler and Botolinum Toxin Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Dermal Filler and Botolinum Toxin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Dermal Filler and Botolinum Toxin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hyaluronic Acid Based Fillers

Figure 10. Product Picture of Non-Hyaluronic Acid Based Fillers

Figure 11. Product Picture of Botulinum Toxin

Figure 12. Global Dermal Filler and Botolinum Toxin Sales Market Share by Type in 2021

Figure 13. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2017-2022)

Figure 14. Dermal Filler and Botolinum Toxin Consumed in Aesthetic Restoration

Figure 15. Global Dermal Filler and Botolinum Toxin Market: Aesthetic Restoration (2017-2022) & (K MT)

Figure 16. Dermal Filler and Botolinum Toxin Consumed in Wrinkle Reduction

Figure 17. Global Dermal Filler and Botolinum Toxin Market: Wrinkle Reduction (2017-2022) & (K MT)

Figure 18. Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2017-2022)

Figure 19. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application in 2021

Figure 20. Dermal Filler and Botolinum Toxin Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Company in 2021

Figure 22. Global Dermal Filler and Botolinum Toxin Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Geographic Region in 2021

Figure 24. Global Dermal Filler and Botolinum Toxin Sales Market Share by Region (2017-2022)

Figure 25. Global Dermal Filler and Botolinum Toxin Revenue Market Share by Country/Region in 2021

Figure 26. Americas Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)

Figure 27. Americas Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)

Figure 28. APAC Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)

Figure 29. APAC Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)

Figure 30. Europe Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)

Figure 31. Europe Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Dermal Filler and Botolinum Toxin Sales 2017-2022 (K MT)

Figure 33. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue 2017-2022 ($ Millions)

Figure 34. Americas Dermal Filler and Botolinum Toxin Sales Market Share by Country in 2021

Figure 35. Americas Dermal Filler and Botolinum Toxin Revenue Market Share by Country in 2021

Figure 36. United States Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Dermal Filler and Botolinum Toxin Sales Market Share by Region in 2021

Figure 41. APAC Dermal Filler and Botolinum Toxin Revenue Market Share by Regions in 2021

Figure 42. China Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Dermal Filler and Botolinum Toxin Sales Market Share by Country in 2021

Figure 49. Europe Dermal Filler and Botolinum Toxin Revenue Market Share by Country in 2021

Figure 50. Germany Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Dermal Filler and Botolinum Toxin Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Dermal Filler and Botolinum Toxin Revenue Market Share by Country in 2021

Figure 57. Egypt Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Dermal Filler and Botolinum Toxin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Dermal Filler and Botolinum Toxin in 2021

Figure 63. Manufacturing Process Analysis of Dermal Filler and Botolinum Toxin

Figure 64. Industry Chain Structure of Dermal Filler and Botolinum Toxin

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390